BACKGROUND: It has been predicted that CD4 C868T, a novel CD4 single-nucleotide polymorphism (SNP) that has been found to be highly prevalent among Africans, changes the tertiary structure of CD4, which may alter susceptibility to human immunodeficiency virus (HIV) infection. METHODS: Participants were from a Kenyan cohort and included 87 uninfected and 277 HIV-1-infected individuals. DNA sequencing was used to determine CD4 genotype. A2.01 cells expressing similar levels of either wild-type CD4 or CD4-Trp240 as well as peripheral blood mononuclear cells from uninfected donors were infected with HIV-1(IIIB) or a Kenyan primary HIV-1 isolate. HIV-1 p24 enzyme-linked immunosorbent assay was used to determine the outcome of infection. RESULTS: CD4 C868T was found to be significantly more prevalent among HIV-1-infected participants than among HIV-1-uninfected participants (P = .002), and C868T was associated with an increased incidence of HIV-1 infection as well (P = .005, log-rank test; P = .009, Wilcoxon test), with an odds ratio of 2.49 (P = .009). Both in vitro and ex vivo models demonstrated a significant association between CD4 C868T and susceptibility to HIV-1 infection (P < .001 and P = .003, respectively). CONCLUSION: Overall, the present study found a strong correlation between CD4 C868T and increased susceptibility to HIV-1 infection. Given the high prevalence of both HIV infection and CD4 C868T in African populations, the effect of this SNP on the epidemic in Africa could be dramatic.
BACKGROUND: It has been predicted that CD4C868T, a novel CD4 single-nucleotide polymorphism (SNP) that has been found to be highly prevalent among Africans, changes the tertiary structure of CD4, which may alter susceptibility to human immunodeficiency virus (HIV) infection. METHODS:Participants were from a Kenyan cohort and included 87 uninfected and 277 HIV-1-infected individuals. DNA sequencing was used to determine CD4 genotype. A2.01 cells expressing similar levels of either wild-type CD4 or CD4-Trp240 as well as peripheral blood mononuclear cells from uninfected donors were infected with HIV-1(IIIB) or a Kenyan primary HIV-1 isolate. HIV-1 p24 enzyme-linked immunosorbent assay was used to determine the outcome of infection. RESULTS:CD4C868T was found to be significantly more prevalent among HIV-1-infectedparticipants than among HIV-1-uninfectedparticipants (P = .002), and C868T was associated with an increased incidence of HIV-1 infection as well (P = .005, log-rank test; P = .009, Wilcoxon test), with an odds ratio of 2.49 (P = .009). Both in vitro and ex vivo models demonstrated a significant association between CD4C868T and susceptibility to HIV-1 infection (P < .001 and P = .003, respectively). CONCLUSION: Overall, the present study found a strong correlation between CD4C868T and increased susceptibility to HIV-1 infection. Given the high prevalence of both HIV infection and CD4C868T in African populations, the effect of this SNP on the epidemic in Africa could be dramatic.
Authors: Kyoung-Mu Lee; Dalsu Baris; Yawei Zhang; H Dean Hosgood; Idan Menashe; Meredith Yeager; Shelia Hoar Zahm; Sophia S Wang; Mark P Purdue; Stephen Chanock; Tongzhang Zheng; Nathaniel Rothman; Qing Lan Journal: Am J Hematol Date: 2010-08 Impact factor: 10.047
Authors: Robert Y Choi; Keith R Fowke; Jennifer Juno; Barbara Lohman-Payne; Julius O Oyugi; Elizabeth R Brown; Rose Bosire; Grace John-Stewart; Carey Farquhar Journal: AIDS Res Hum Retroviruses Date: 2011-09-27 Impact factor: 2.205
Authors: R Y Choi; C Farquhar; J Juno; D Mbori-Ngacha; B Lohman-Payne; F Vouriot; S Wayne; J Tuff; R Bosire; G John-Stewart; K Fowke Journal: Clin Exp Immunol Date: 2010-02-02 Impact factor: 4.330
Authors: Robert E Sealy; Bart G Jones; Sherri L Surman; Kristen Branum; Nanna M Howlett; Patricia M Flynn; Julia L Hurwitz Journal: Viral Immunol Date: 2015-11-06 Impact factor: 2.257
Authors: Jennifer Juno; Jeffrey Tuff; Robert Choi; Catherine Card; Joshua Kimani; Charles Wachihi; Sandra Koesters-Kiazyk; T Blake Ball; Carey Farquhar; Francis A Plummer; Grace John-Stewart; Ma Luo; Keith R Fowke Journal: Retrovirology Date: 2012-01-03 Impact factor: 4.602
Authors: Gregory Q Del Prete; Brandon F Keele; Jeannine Fode; Keyur Thummar; Adrienne E Swanstrom; Anthony Rodriguez; Alice Raymond; Jacob D Estes; Celia C LaBranche; David C Montefiori; Vineet N KewalRamani; Jeffrey D Lifson; Paul D Bieniasz; Theodora Hatziioannou Journal: PLoS Pathog Date: 2017-09-25 Impact factor: 6.823